Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

DuPont Merck reports ester prodrugs for glaucoma

Dec. 19, 1996

VISX supplemental PMA slated for review

Dec. 12, 1996

InSite Vision completes preliminary clinical trial of ophthalmic drug candidate

Dec. 9, 1996

Neuregulin polypeptides described for treating retinal disorders

Nov. 26, 1996

Cambridge NeuroScience/Allergan ophthalmic disease collaboration

Nov. 26, 1996

P&U and PRIZM begin ophthalmological collaboration

Nov. 25, 1996

New market introduction for dorzolamide

Nov. 21, 1996

Oculex dexamethasone intraocular delivery system superior to eye drops

Nov. 20, 1996

InSite Vision strengthens position on genetic research into glaucoma

Nov. 1, 1996

Hybridon's VEGF-targeting antisense drugs for retinal neovascularization

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...